The opening number is a prepayment with its conditions blanked out
Land on the pricing page and the first compounded figure you see is the low one. Its qualifying lines are served empty. There is no visible text beside it saying what it requires.
It requires three things. You must be a first-time GLP-1 user, you must pay for three months up front, and you must live in one of the states where that starter pack is offered. None of that renders. The condition exists on the product page, not beside the number.
The rate that holds afterward is the month-to-month one, and it is more than half again as much for semaglutide. That is the figure to carry into a comparison. Treat the opening number as a promotion you may not qualify for.
Everything else about the pricing is unusually open
Once past that, Zappy does something most sellers here will not. It publishes the month-to-month, three-month and six-month rate for both compounded drugs, and prints the total behind each multi-month plan rather than only the divided-down monthly figure.
That means you can see what a commitment actually costs you in full, not just what it makes the monthly number look like. Very little of this roster shows the total.
Zappy also charges no membership, and says so beside its own comparison table naming two rivals that do. Seventeen of the forty-nine sellers here charge no membership, so it is not alone, but it is the one that argues the point in public.
On the brand side it separates the bills and adds them up
For Wegovy and Zepbound, Zappy sells the care plan only. The drug is bought from the manufacturer's own channel and billed separately.
What is good here is that Zappy does the arithmetic itself on the page — care plan, medication, total — instead of leaving a reader to discover the second charge at checkout. Most sellers with a brand-name route do not print the sum.
One row breaks the pattern. The Wegovy pill option charges the same care plan but publishes no medication figure at all, so that line never adds up to anything. If the oral brand is what you want, you will have to get the drug cost elsewhere before you can compare it.
The February 2026 warning letter
Kare Solutions LLC, which operates Zappy, received an FDA warning letter dated February 2026. The letter concerns labelling on compounded semaglutide, tirzepatide and liraglutide that the agency found suggested Zappy compounded the drugs when it does not.
Read what that is and what it is not. It is a finding about how the product was presented, not a recall and not a finding about the medication a patient received. It is still an open enforcement action against the operating company, and it is public.
Three of the forty-nine sellers on this roster carry a recorded FDA letter. If enforcement history is a filter for you, this is one of the three, and the letter number and date are on the row so you can read the agency's own text rather than ours.
Named pharmacies, unnamed clinicians
Zappy names pharmacies twice — once on a dedicated partner page and once as the dispensing pharmacy on the semaglutide product page. Only ten of the forty-nine sellers here name a compounding pharmacy at all, so that is genuinely above average.
It names no clinician. There is no medical director, no prescriber, no individual anywhere, and the About page is a dead link. Eighteen of the forty-nine name nobody, so Zappy is in a crowd, but a crowd is not a defense.
One more inconsistency worth knowing before you pay: the plan cards read as though medication is included, while the same page answers a fee question by saying medication costs are separate. Ask which applies to the plan you are buying.
Zappy Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $249/mo"Most Flexible / $249 /month / All doses / Billed monthly / Monthly virtual visits". The same page also publishes "3-Month Plan: $229/mo, (Total: $687)" and "6-Month Plan - $209/mo (Total: $1254)". | September 2026source |
| Tirzepatide (compounded) | $349/mo"$349 /month / Billed monthly". The same page also publishes "3-Month Plan: $329/mo, (Total: $987)" and "6-Month Plan - $299/mo (Total: $1794)". | September 2026source |
| Semaglutide (brand) | $99/mo"$99 / monthly (care plan) . Medication billed separately (~$499/month via NovoCare)". The Wegovy product page states the arithmetic itself: "Medical care: $99/mo. Medication cost: $499/mo collected directly by Novo Nordisk. Total: ~$598/mo." | September 2026source |
| Tirzepatide (brand) | $99/mo"$99 / month (care plan). Medication billed separately ($349-$649/month via Lilly Direct)". The Zepbound page adds "Cost of medication is separate and through Eli Lilly / $349/mo (2.5 mg), $499-$649/mo (5-10 mg)". | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 56 providers reviewed here are paid partners today; the other 52 are not. See how this works.
See Zappy Health's current price →Good fit if
- Readers who want every plan length and every total in front of them before handing over an email address, rather than one starting figure.
- People who want no membership charge layered on top of the medication, stated plainly rather than buried.
- Buyers on the brand-name route who want the care fee and the manufacturer's drug price separated and then added together on the same page.
- Anyone who wants the compounding pharmacy named and checkable, which only ten of the forty-nine sellers here do.
Look elsewhere if
- Anyone in Hawaii. Zappy states in its own words that it serves all U.S. states except that one.
- Readers who will not buy from a company with an open FDA enforcement action. Forty-six of the forty-nine sellers here carry none; Cora Health and Maximus are two that also publish full price ladders.
- Patients who need a named prescriber or medical director before starting. Cora Health names its medical director and prescribing group; Midi Health names individual clinicians.
- Anyone shopping the headline number. The figure the pricing page opens with is a first-time-user three-month prepayment offered in select states only, and its conditions do not render.
How this review was verified
- Read the compounded semaglutide and tirzepatide product pages at their source URLs and logged every published tier — month to month, three months, six months — with the multi-month totals and the date read.
- Recorded the low headline figure as an intro offer rather than a price, because it is a first-time-user three-month prepayment, and kept the select-states restriction in its qualifier.
- Confirmed on the live pricing page that the qualifying lines beside that headline figure are served empty, which is why it is not treated as the ongoing rate anywhere on this site.
- Read the pricing page's brand-name rows and logged the care-plan charge with the manufacturer's medication cost quoted verbatim beside it, so neither can be read as a complete monthly bill.
- Logged the FDA warning letter by number, issue date and the agency's own URL, and checked that it names Kare Solutions LLC as the operator rather than a pharmacy.
- Read the service-area sentence in place on both product pages and recorded the single excluded state, rather than converting a pharmacy-licensing line into a coverage claim.